Finally, concerning the amendment of the offer and the risks of cross-compensation, the Commission noted that, whilst the commitment not to re-sell the product concerned would limit some of the cross-compensation risks the principal issue, namely the MIP being applied to transactions between related entities, remains.
Enfin, en ce qui concerne la modification de l'offre et les risques de compensation croisée, la Commission a constaté que, bien que l'engagement de ne pas revendre le produit concerné limiterait certains risques de compensation croisée, la question principale, à savoir le PMI appliqué aux transactions entre entités liées, reste posée.